Capítulo 1769: Chapter 1256: Steady Progress (Part 3)
Through the combined molecules, they were then fed into the virtual cell screening platform, where an enhanced version of Chu Xiaoxiao’s AI model predicted their immune activation effects and potential cytotoxicity.
Ultimately, only a few dozen molecules reached the “final round.”
At this mont, the reinforcent learning AI of the data hub began to co into play. It analyzed the common structural features, physicochemical properties, and performance data in previous modules of these dozens of successful molecules, summarizing a set of “success patterns.” Then, it fed these patterns back to the initial design engine.
The second round of AI design was no longer a blind search starting from scratch but a targeted optimization based on the “successful experiences” of the first round! The newly generated molecules started from a higher baseline.
This cycle repeated hundreds of tis within the System Space at an astonishing speed. Each iteration led the central AI to a deeper understanding of “how to design good molecules,” even beginning to uncover so counterintuitive structure-effect relationships that human scientists might find difficult to perceive based on experience.
When the light of dawn arrived once more, Yang Ping exited the System Space with three candidate molecule sequences in his mind, optimized through countless virtual iterations and outstanding in all simulation stages. These molecules did not arise from his flashes of inspiration but were the crystallization that this nascent autonomous research ecosystem, driven by AI, had “self-evolved”!
In the morning eting, Yang Ping shared the sequences and information of these three candidate molecules with the team.
“Are these… platform autonomously designed?” He Zijian looked at the exquisite, yet slightly unconventional structures, utterly astounded. He doubted that even with AI assistance, he could conceive such designs.
“Yes.” Yang Ping nodded calmly, “Our platform now possesses the initial capabilities for ‘learning’ and ‘evolution.’ Next, we need to synthesize them in reality and conduct comprehensive in vitro and in vivo validation.”
He assigned the new tasks:
He Zijian: Coordinate with the synthesis outsourcing company to synthesize these three candidate molecules as soon as possible.
Wang Chao and Chu Xiaoxiao: Prepare the validation process, and once the molecules are in hand, imdiately conduct high-standard evaluation of biological activity and specificity.
Liu Yang: Start developing the large-scale production process for these three molecules to prepare for future transformation.
Jiang Jitong: Seek and evaluate compliant cooperation platforms capable of conducting preclinical animal experints.
After the eting, Yang Ping stood alone by his office window. Below, the city’s pulse was strong and vigorous. His heart was equally surging with an unprecedented torrent.
He knew they were about to take the most critical step. If these three candidate molecules validated successfully in reality, it would an not only the dawn of a new type of adjuvant but also a victory for a paradigm. It would prove that a completely different path than relying on Western scientific infrastructure was feasible, and possibly more efficient and creative.
What he was building was not just a tool to solve the current predicant but an innovative life-form capable of continuous self-learning, self-evolving, and nurturing infinite possibilities. The value of this system had already transcended immune adjuvants, or even drug research and developnt itself. It was a thodology, a Chinese solution to achieve high-level technological self-reliance and strength in a “neck-choking” environnt.
“The hardware supply chain, the software system ecosystem… the foundation has been laid.” Yang Ping’s gaze stretched into the distance, where a larger chessboard seed to be unfolding, “It’s ti for this system to embrace more complex, more severe challenges.”
He decided to take a bigger gamble, no longer on the success or failure of a single product, but on whether China can truly have the ability and confidence to define the rules and lead the future in the cutting-edge field of biotechnology.
Now he firmly believes it is entirely possible. The Ruixing-ford alliance has completed an initial aggregation of talent, and given a certain amount of ti, they will undoubtedly be able to complete the R&D, improvent, and production of cutting-edge laboratory research equipnt, building their own research platform.
This showdown has just reached its climax.
User Comments
0 comments from readers